Author

Emma C. Rowland

Georgetown UniversityORCID 0000-0003-4294-3050Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Anna M. JermakowicziD· 1 shared Matthew D’AntuonoiD· 1 shared Nagi G. AyadiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna M. JermakowiczORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyJournal of Biological ChemistryPeer-reviewedFeb 25, 2025

MAT2a and AHCY Inhibition Disrupts Antioxidant Metabolism and Reduces Glioblastoma Cell Survival

Emma C. Rowland, Matthew D’Antuono, Anna M. Jermakowicz, Nagi G. Ayad

This study identifies MAT2A and AHCY as critical for glioblastoma survival by regulating antioxidant metabolism, showing their inhibition reduces cell viability and oxidative stress.

12 citationstop 3%

humanbulk RNA-seq

𝕏 PostBluesky